Morgan Health, a JPMorgan Chase & Co. (NYSE: JPM) business unit focused on improving the quality, equity and affordability of employer-sponsored health care, made a $25M investment in Kindbody, a NYC-based fertility clinic network and global family-building benefits provider.
The amount of the deal was not disclosed. Dr. Cheryl Pegus, a Managing Director with Morgan Health Ventures, will join Kindbody’s Board of Directors.
Founded in late 2018 and led by Gina Bartasi, Chairwoman, Kindbody is a fertility clinic network and global family-building benefits provider for employers offering the full-spectrum of reproductive care from preconception to postpartum through menopause.
It currently is the fertility benefits provider for 112 large employers, covering more than 2.4 million lives. The company’s clients span virtually every industry and include Walmart, Medtronic, Lyft and GEICO. Kindbody serves patients at 32 signature clinics and hundreds of partner clinics in the U.S. Its clinically-managed program covers the full-spectrum of reproductive health, including both female and male fertility, which encompasses fertility assessments and education, fertility preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption, as well as a full continuum of reproductive care including physical, mental and emotional support.
The company has raised $315M in funding from leading investors including Perceptive Advisors, Morgan Health, GV (formerly Google Ventures), RRE Ventures, Claritas Health Ventures, Rock Springs Capital, NFP Ventures, Whatif Ventures and TQ Ventures.
FinSMEs
01/05/2023